Why should I check a uric acid level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Check a Uric Acid Level?

You should check a uric acid level primarily to guide treatment decisions in patients with confirmed or suspected gout, to monitor urate-lowering therapy, and to assess cardiovascular/renal risk in selected high-risk populations—but never to diagnose gout during an acute attack or as a standalone diagnostic test.

Primary Indications for Checking Uric Acid

1. Monitoring Urate-Lowering Therapy (Most Important Clinical Use)

Once you've diagnosed gout and initiated treatment, serum uric acid (SUA) monitoring is essential:

  • Target: <6 mg/dL (360 μmol/L) for all patients on urate-lowering therapy (ULT) 1
  • Target: <5 mg/dL (300 μmol/L) for severe gout with tophi, chronic arthropathy, or frequent attacks—until crystal dissolution occurs 1
  • Lifelong monitoring is required because 40% of successfully treated patients experience flare recurrence after ULT withdrawal 1
  • Check regularly to titrate medications upward until target is achieved, then maintain monitoring to ensure sustained control 1

2. Risk Stratification (Not Diagnosis)

Hyperuricemia is a major risk factor for developing gout, but checking SUA has specific limitations:

  • Epidemiological context: Higher SUA levels strongly predict future gout development. Men with SUA >6 mg/dL have 4.6× higher risk; women have 17× higher risk 2
  • Cardiovascular/renal risk assessment: Elevated SUA associates with increased cardiovascular mortality, heart failure, stroke, and CKD progression 3. In high-risk populations (hypertension, CKD, established CVD), SUA measurement can improve risk stratification 3
  • However: Many people with hyperuricemia never develop gout, and asymptomatic hyperuricemia should NOT be routinely treated 4

3. When NOT to Rely on Uric Acid for Diagnosis

Critical pitfall: SUA has limited diagnostic value, especially during acute gout attacks 2:

  • 10-39% of patients with crystal-proven gout have normal SUA levels during acute flares 2, 5, 6
  • SUA behaves as a negative acute phase reactant—it temporarily drops during inflammation and stress 2
  • Renal excretion of uric acid increases during acute episodes 2
  • Prior risk factors may have been modified (stopped diuretics, weight loss, reduced alcohol) 2

The gold standard for gout diagnosis remains monosodium urate (MSU) crystal identification in synovial fluid or tophi aspirate 4, 5. If crystal identification isn't possible, use imaging (ultrasound, dual-energy CT) rather than relying on SUA alone 5.

4. Selected Special Populations

Check 24-hour urinary uric acid excretion (not serum) in specific scenarios 2:

  • Family history of young-onset gout
  • Gout onset before age 25
  • History of renal calculi
  • To identify uric acid overexcretors (>1000 mg/day) who may benefit from specific treatment approaches

However, the 2020 ACR guidelines conditionally recommend against routine urinary uric acid checking for patients considered for uricosuric treatment, given challenges with collection and limited evidence 7.

Common Clinical Scenarios

Scenario A: Patient with First Acute Monoarthritis

  • Do NOT check SUA to diagnose gout during the acute attack
  • Aspirate joint fluid for crystal identification if feasible
  • If aspiration not possible, use clinical criteria + imaging (ultrasound for double contour sign, tophi)
  • Check SUA after the acute episode resolves (at least 2 weeks later) for baseline and treatment planning 2, 5

Scenario B: Patient with Confirmed Gout Starting ULT

  • Check baseline SUA before starting allopurinol or febuxostat
  • Recheck every 2-4 weeks while titrating dose upward 1
  • Once target achieved (<6 mg/dL or <5 mg/dL for severe disease), monitor regularly (every 6-12 months) to maintain lifelong control 1

Scenario C: Patient with Asymptomatic Hyperuricemia

  • Do NOT treat pharmacologically to prevent gout, renal disease, or cardiovascular events 4
  • Consider checking in high-risk populations (CKD, hypertension, established CVD) for risk stratification purposes 3
  • Advise lifestyle modifications: weight loss, limit alcohol (especially beer/spirits), avoid sugar-sweetened drinks, reduce meat/seafood, encourage low-fat dairy 1

Key Caveats

  1. Never diagnose gout based on elevated SUA alone—sensitivity is only 67% and specificity 78% 2
  2. Never exclude gout based on normal SUA—up to 39% of gout patients have normal levels during attacks 2, 5, 6
  3. Avoid checking SUA <3 mg/dL long-term—potential neuroprotective effects of uric acid make extremely low levels undesirable 1
  4. Gender-specific interpretation: Men naturally have higher SUA levels than women; use population-specific reference ranges 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.